Medical Program: Dissecting Determinants of Disease Progression in NSCLC

Dissecting Determinants of Disease Progression in NSCLC

Dissecting Determinants of Disease Progression in NSCLC
RestartResume
Successful identification of these underlying factors offers us insights into disease development in our NSCLC patients.
  • Overview

    With many factors yet to be discovered, Dr. Howard Jack West targets the clinical characteristics and molecular markers associated with disease progression in non-small cell lung cancer (NSCLC) patients. As he presents patterns observed for decades, Dr. West reveals other often underrecognized clues that drive disease progression.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

     

Facebook Comments

Sign up for the Global Oncology Academy newsletters.
Comprehensive Oncology Education.

Better education for a better you.

* Required
Optional

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free